
APIs
Acyclovir
Acyclovir is a white crystalline powder, classified as a synthetic purine nucleoside analogue with potent antiviral activity. It is widely used for the treatment of infections caused by herpes simplex virus (HSV) and varicella-zoster virus (VZV). Acyclovir works by inhibiting viral DNA synthesis, thereby limiting the replication of the virus within host cells. Due to its selective activity and proven clinical efficacy, Acyclovir remains a mainstay in antiviral therapy across multiple dosage forms.
Specifications
| Parameter | Specification |
|---|---|
| Standards Compliance | Complies with IP/BP/USP/Ph.Eur. quality standards |
| Appearance | White crystalline powder |
| Assay | ≥98.5% (on dried basis) |
| Identification | Conforms to standard tests |
| Loss on Drying | ≤0.5% |
| Residue on Ignition | ≤0.1% |
| Heavy Metals | ≤10 ppm |
Why Choose Prachin for Acyclovir
Potent antiviral activity against HSV and VZV
Proven efficacy in both acute and suppressive antiviral therapy
Excellent stability profile under standard storage
Suitable for a range of formulations: tablets, capsules, creams, and suspensions
Minimal systemic toxicity with high therapeutic index
Common Applications
Pharmaceutical
Used as the active ingredient in oral, topical, and parenteral formulations for the treatment and prevention of herpes simplex infections, herpes zoster (shingles), and varicella (chickenpox)